These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1065 related articles for article (PubMed ID: 17683854)

  • 21. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
    Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.
    Swindle P; Eastham JA; Ohori M; Kattan MW; Wheeler T; Maru N; Slawin K; Scardino PT
    J Urol; 2005 Sep; 174(3):903-7. PubMed ID: 16093984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complications, urinary continence, and oncologic outcome of 1000 laparoscopic transperitoneal radical prostatectomies-experience at the Charité Hospital Berlin, Campus Mitte.
    Lein M; Stibane I; Mansour R; Hege C; Roigas J; Wille A; Jung K; Kristiansen G; Schnorr D; Loening SA; Deger S
    Eur Urol; 2006 Dec; 50(6):1278-82; discussion 1283-4. PubMed ID: 16846677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
    Walz J; Chun FK; Klein EA; Reuther A; Graefen M; Huland H; Karakiewicz PI
    Eur Urol; 2009 Feb; 55(2):412-19. PubMed ID: 19027223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Operative details and oncological and functional outcome of robotic-assisted laparoscopic radical prostatectomy: 400 cases with a minimum of 12 months follow-up.
    Murphy DG; Kerger M; Crowe H; Peters JS; Costello AJ
    Eur Urol; 2009 Jun; 55(6):1358-66. PubMed ID: 19147274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
    Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML
    J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoscopic extraperitoneal radical prostatectomy after previous transurethral resection of prostate: oncologic and functional outcomes of 100 cases.
    Do M; Haefner T; Liatsikos E; Kallidonis P; Hicks J; Dietel A; Horn LC; Rabenalt R; Stolzenburg JU
    Urology; 2010 Jun; 75(6):1348-52. PubMed ID: 19914701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.
    Delongchamps NB; Zerbib M; Mejean A; Rouach Y; Debre B; Peyromaure M
    Can J Urol; 2009 Oct; 16(5):4813-9. PubMed ID: 19796456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Radical prostatectomy as monotherapy for locally advanced prostate cancer (T3a): 12 years follow-up].
    Isorna Martínez de la Riva S; Belón López-Tomasety J; Marrero Domínguez R; Alvarez Cruz E; Santamaría Blanco P
    Arch Esp Urol; 2004 Sep; 57(7):679-92. PubMed ID: 15536949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies.
    Catalona WJ; Carvalhal GF; Mager DE; Smith DS
    J Urol; 1999 Aug; 162(2):433-8. PubMed ID: 10411052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of surgical margin status for biochemical recurrence following radical prostatectomy.
    Hashimoto K; Masumori N; Takei F; Fukuta F; Takahashi A; Itoh N; Hasegawa T; Tsukamoto T
    Jpn J Clin Oncol; 2008 Jan; 38(1):31-5. PubMed ID: 18203710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving the preservation of the urethral sphincter and neurovascular bundles during open radical retropubic prostatectomy.
    Montorsi F; Salonia A; Suardi N; Gallina A; Zanni G; Briganti A; Deho' F; Naspro R; Farina E; Rigatti P
    Eur Urol; 2005 Dec; 48(6):938-45. PubMed ID: 16257111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nerve sparing laparoscopic radical prostatectomy: our technique.
    Curto F; Benijts J; Pansadoro A; Barmoshe S; Hoepffner JL; Mugnier C; Piechaud T; Gaston R
    Eur Urol; 2006 Feb; 49(2):344-52. PubMed ID: 16413102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term evaluation of survival, continence and potency (SCP) outcomes after robot-assisted radical prostatectomy (RARP).
    Ficarra V; Borghesi M; Suardi N; De Naeyer G; Novara G; Schatteman P; De Groote R; Carpentier P; Mottrie A
    BJU Int; 2013 Aug; 112(3):338-45. PubMed ID: 23470027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bladder neck preservation during radical retropubic prostatectomy and postoperative urinary continence.
    Razi A; Yahyazadeh SR; Sedighi Gilani MA; Kazemeyni SM
    Urol J; 2009; 6(1):23-6; discussion 26. PubMed ID: 19241337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long-term results of retropubic radical prostatectomy].
    Petrov SB; Rakul SA; Galimov RD
    Vestn Khir Im I I Grek; 2010; 169(1):117-22. PubMed ID: 20387620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Achieving optimal outcomes after radical prostatectomy.
    Saranchuk JW; Kattan MW; Elkin E; Touijer AK; Scardino PT; Eastham JA
    J Clin Oncol; 2005 Jun; 23(18):4146-51. PubMed ID: 15961762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.
    Magheli A; Rais-Bahrami S; Carter HB; Peck HJ; Epstein JI; Gonzalgo ML
    J Urol; 2007 Oct; 178(4 Pt 1):1277-80; discussion 1280-1. PubMed ID: 17698121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
    Magheli A; Rais-Bahrami S; Peck HJ; Walsh PC; Epstein JI; Trock BJ; Gonzalgo ML
    J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laparoscopic radical prostatectomy - results of 200 consecutive cases in a Canadian medical institution.
    Tse E; Knaus R
    Can J Urol; 2004 Apr; 11(2):2172-85. PubMed ID: 15182406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.